Clinical Trials in Arizona

Showing 9841-9860 of 14,395 trials

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

NCT01597492

The purpose of this study is to assess the impact of belimumab on immune response to pneumococcal vaccine in subjects with Systemic Lupus Erythematosus (SLE).

Systemic Lupus Erythematosus

Human Genome Sciences Inc., a GSK Company79 participantsStarted May 2012

Birmingham, Alabama, United States • Paradise Valley, Arizona, United States • Shreveport, Louisiana, United States +12 more locations

COMPLETEDPhase 438 miles

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

NCT00282295

New immunization recommendations in the US include vaccination of adolescents against pertussis and meningococcal disease. The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends that Tdap (Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine Adsorbed) and MCV4 (Meningococcal conjugate vaccine against serotypes A, C, Y and W-135) vaccines be administered to adolescents at the same office visit if vaccination with both vaccines is indicated. Therefore, this study is designed to evaluate the safety and immunogenicity of a booster vaccination with Boostrix co-administered with Menactra as compared to the administration of either vaccine alone in healthy adolescents 11 - 18 years of age.

Acellular PertussisTetanusDiphtheria

GlaxoSmithKline1,344 participantsStarted Jan 2006

Chandler, Arizona, United States • Little Rock, Arkansas, United States • Fountain Valley, California, United States +21 more locations

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

Find Trials by Condition in Arizona

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

Plasma and Intrapulmonary Concentrations Study of WCK 5222

The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Resilience Against Depression Disparities (Also Known as Resilience Education to Reduce Depression Disparities)

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

SF1126 for Patients With Relapsed or Refractory Neuroblastoma

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Transfusion Requirements in Cardiac Surgery III

Automated Screen for Fetal Aneuploidy